Trends and variations in utilization and costs of radiotherapy for prostate cancer: A SEER medicare analysis from 2007 through 2016
08/02/2021
/
Publications
/
IMPT
Based on the SEER database, this study reported that for Medicare beneficiaries with a first-time diagnosis of prostate cancer, the utilization of IMRT, proton...
Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer.
03/03/2020
/
Publications
/
IMRT
IMPT
Published in JCO (Journal of Clinical Oncology), this randomized trial compared total toxicity burden (TTB) and progression-free survival (PFS) between PBT and...
The Potential Role of Intensity-Modulated Proton Therapy in Hepatic Carcinoma in Mitigating the Risk of Dose De-Escalation
10/12/2020
/
Publications
/
VMAT
IMPT
A cohort of 30 patients was retrospectively selected as "at-risk" of dose de-escalation due to the proximity of the target volumes to dose-limiting healthy...
Toxicity and Survival After IMPT Versus Passive Scattering PT for NSCLC.
10/10/2020
/
Publications
/
Toxicity
IMPT
This MD Anderson study compared toxicity profiles and clinical outcomes after IMPT versus PSPT for 139 patients with locally advanced NSCLC. Compared to the...
Proton Therapy in NSCLC
11/11/2018
/
Publications
/
IMPT
Immunotherapy
A review on PBT for NSCLC. The review pointed out that despite early results suggesting improvements or at least comparable outcomes, the most recent randomized...
Initial experience with IMPT for intact, clinically localized pancreas cancer.
08/04/2018
/
Publications
/
IMPT
Chemotherapy
A Mayo Clinic study reported outcomes of IMPT for intact and clinically localized pancreatic cancer. 13 patients with localized pancreatic cancer underwent...
Patterns of Local-Regional Failure after IMRT or Passive Scattering PT with Concurrent Chemotherapy for NSCLC.
08/08/2018
/
Publications
/
IMPT
Published in the Red Journal, this retrospective analysis by MD Anderson group reviewed 212 patients treated with IMRT and PT, most (152 [72%]) had no failure...
Advanced radiation techniques for locally advanced NSCLC: IMRT and proton therapy.
08/08/2018
/
Publications
/
IMPT
IMRT
This review article examined clinical outcomes data of IMRT and PBT for locally advanced NSCLC. This review pointed out that PBT is not considered the standard...
Reirradiation for locoregionally recurrent non-small cell lung cancer.
08/08/2018
/
Publications
/
Reirradiation
IMPT
Survival
In the context of definitive retreatment, increasing reRT dose can potentially improve OS and offer a chance of cure, particularly in patients with limited loco...
Clinical outcomes of intensity modulated proton therapy and concurrent chemotherapy in esophageal carcinoma (EC).
11/06/2017
/
Publications
/
IMPT
Chemotherapy
Toxicity
19 patients with EC treated with IMPT concurrently with chemotherapy. Clinical complete response was achieved in 84%.
The most common grade 3 acute toxicities...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.